BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
Rheumatology (Oxford)
.
2008 Jun;47(6):924-5.
doi: 10.1093/rheumatology/kel216a.
Epub 2006 Aug 28.
Authors
K Chakravarty
1
,
H McDonald
,
T Pullar
,
A Taggart
,
R Chalmers
,
S Oliver
,
J Mooney
,
M Somerville
,
A Bosworth
,
T Kennedy
;
British Society for Rheumatology, British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group
;
British Association of Dermatologists (BAD)
Affiliation
1
Harold Wood Hospital, BHR NHS Trust, Romford, Essex RM7 OBE, UK. Kuntal.Chakravarty@bhrhospitals.nhs.uk
PMID:
16940305
DOI:
10.1093/rheumatology/kel216a
No abstract available
Publication types
Practice Guideline
MeSH terms
Antirheumatic Agents / adverse effects
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / drug therapy*
Drug Monitoring / methods
Evidence-Based Medicine
Humans
Interprofessional Relations
Medical Audit
Substances
Antirheumatic Agents